SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "L773:0959 8049 OR L773:1879 0852 "

Sökning: L773:0959 8049 OR L773:1879 0852

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  •  
5.
  • Heldin, Carl-Henrik (författare)
  • Meet the ERC
  • 2012
  • Ingår i: European Journal of Cancer. - 0959-8049 .- 1879-0852. ; 48:S5, s. S5-S5
  • Tidskriftsartikel (refereegranskat)
  •  
6.
  •  
7.
  • Luoma, ML, et al. (författare)
  • Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer
  • 2003
  • Ingår i: European Journal of Cancer. - : Elsevier. - 1879-0852 .- 0959-8049. ; 39:10, s. 1370-1376
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of the study was to investigate whether baseline quality of life (QoL) and changes in QoL scores from baseline are prognostic for time to progression (TTP) and/or overall survival (OS) in patients with advanced breast cancer receiving docetaxel (T) or sequential methotrexate and 5-fluorouracil (MF). QoL was assessed at baseline and before each treatment using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ-C30). Survival curves and probabilities were estimated using the Kaplan-Meier technique. The Cox proportional hazards regression model was used for both the univariate and multivariate analyses to explore relationships between baseline QoL variables and TTP, as well as OS. In the univariate analysis, more severe pain and fatigue at baseline were predictive for a shorter OS; global QoL, physical functioning and appetite loss had a borderline significance (P=0.0130 for global QoL; P=0.0256 for physical functioning: P=0.0149 for appetite loss). World Health Organization (WHO) performance status was significantly predictive for OS. In the multivariate analysis, more severe pain at baseline was predictive for a shorter OS. In contrast, baseline QoL had no prognostic value for the duration of TTP. QoL change scores from baseline QoL predicted neither OS nor TTP. Our findings suggest that while QoL measurements are important in evaluating patients' QoL, they have no great importance in predicting primary clinical endpoints such as TTP or OS in advanced breast cancer patients. (C) 2002 Elsevier Science Ltd. All rights reserved.
  •  
8.
  • Malmström, P, et al. (författare)
  • Breast conservation surgery, with and without radiotherapy, in women with lymph node-negative breast cancer: a randomised clinical trial in a population with access to public mammography screening.
  • 2003
  • Ingår i: European journal of cancer (Oxford, England : 1990). - : Elsevier. - 0959-8049. ; 39:12, s. 1690-1697
  • Tidskriftsartikel (refereegranskat)abstract
    • The effect of postoperative radiotherapy after sector resection for stage I-II lymph node-negative breast cancer was evaluated in a patient population with access to public mammographical screening. 1187 women were randomised to no further treatment or postoperative radiotherapy following a standardised sector resection and axillary dissection. Radiation was administered to a dose of 48-54 Gy. Median age was 60 years, and median size of the detected tumours was 12 mm. Of the women 65% had their tumours detected by mammographical screening. The relative risk (RR) of ipsilateral breast recurrence was significantly higher in the non-irradiated patients compared with the irradiated patients, RR=3.33 (95% Confidence Interval (CI) 2.13-5.19, P<0.001). The corresponding cumulative incidence at 5 years was 14% versus 4%, respectively. Overall survival (OS) was similar, RR=1.16 (95% CI 0.81-1.65, P=0.41), with 5 year probabilities of 93 and 94%, respectively. Recurrence-free survival (RFS) at 5 years was significantly lower in the non-irradiated women, 77% versus 88% (P<0.001). Although women above 49 years of age, whose tumours were detected with mammographical screening, had the lowest rate of ipsilateral breast recurrence in this study, the cumulative incidence of such event amounted to 10% at 5 years if radiotherapy was not given. Such a recurrence rate has been considered as unacceptably high, but is, however, in the same range as that reported after lumpectomy and postoperative radiotherapy in published series.
  •  
9.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (662)
konferensbidrag (189)
forskningsöversikt (12)
Typ av innehåll
refereegranskat (607)
övrigt vetenskapligt (256)
Författare/redaktör
Bergh, J (39)
Holmberg, L (32)
Glimelius, B (29)
Brandberg, Y (25)
Hemminki, K (25)
Glimelius, Bengt (22)
visa fler...
Lagergren, J (21)
Garmo, H (21)
Adolfsson, J. (19)
Holmberg, Lars (18)
Wengstrom, Y (18)
Wengström, Yvonne, 1 ... (18)
Weiderpass, E (17)
Pukkala, E (17)
Stattin, P (17)
Sandelin, K (16)
Stattin, Pär (16)
Olsson, Håkan (15)
Hansson, J. (15)
Hemminki, Kari (15)
Johansson, H (14)
LAMBE, M (14)
Ringborg, U (14)
Fernö, Mårten (13)
Nilsson, S (13)
Hall, P (13)
Czene, K (12)
Frisell, J (12)
Borg, Åke (12)
Adami, HO (11)
Garmo, Hans (11)
Van Hemelrijck, M (11)
Sundquist, Jan (11)
Pahlman, L (11)
Blomqvist, C (10)
Sundquist, Kristina (10)
Kogner, P (10)
Wolk, A (10)
Karlsson, E (10)
Anderson, H (10)
Anderson, Harald (10)
Henriksson, R (9)
Hjorth, Lars (9)
Påhlman, Lars (9)
Lambe, Mats (9)
Wolk, Alicja (9)
Adolfsson, Jan (9)
Nordenskjöld, Bo (9)
Bergkvist, L. (9)
Ingvar, C (9)
visa färre...
Lärosäte
Karolinska Institutet (518)
Lunds universitet (145)
Uppsala universitet (140)
Umeå universitet (69)
Göteborgs universitet (52)
Linköpings universitet (39)
visa fler...
Örebro universitet (28)
Karlstads universitet (9)
Linnéuniversitetet (5)
Kungliga Tekniska Högskolan (2)
Stockholms universitet (2)
Chalmers tekniska högskola (2)
Ersta Sköndal Bräcke högskola (2)
Mälardalens högskola (1)
Jönköping University (1)
Mittuniversitetet (1)
Södertörns högskola (1)
Högskolan i Halmstad (1)
Högskolan Dalarna (1)
visa färre...
Språk
Engelska (863)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (335)
Naturvetenskap (4)
Samhällsvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy